Home › Funds › CAPITAL WEALTH MANAGEMENT, LLC › VRTX
CAPITAL WEALTH MANAGEMENT, LLC position in VRTX
VERTEX PHARMACEUTICALS INC · Health Care
CAPITAL WEALTH MANAGEMENT, LLC reported holding 400 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$209K, representing 0.05% of its reported portfolio and ranking #39 among its reported holdings. CAPITAL WEALTH MANAGEMENT, LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How CAPITAL WEALTH MANAGEMENT, LLC's VRTX position evolved
CAPITAL WEALTH MANAGEMENT, LLC first disclosed a stake in VRTX in Q3 2026 at 400 shares (US$209K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 400 | $209.12K | New |
About VRTX and 13F data
VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VRTX
- Capital World Investors 25.97M sh · $13.58B · Q3 2026
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Capital Research Global Investors 17.81M sh · $9.31B · Q3 2026
- Invesco Ltd 8.28M sh · $4.33B · Q3 2026
- Capital International Investors 5.06M sh · $2.65B · Q3 2026
- Franklin Resources 4.46M sh · $2.45B · Q3 2026
- LOOMIS SAYLES & CO L P 3.62M sh · $1.89B · Q3 2026
- JENNISON ASSOCIATES LLC 3.00M sh · $1.49B · Q2 2026
- ALLIANCEBERNSTEIN L.P. 3.02M sh · $1.35B · Q2 2026
- VICTORY CAPITAL MANAGEMENT INC 2.56M sh · $1.34B · Q3 2026
- Janus Henderson Group 2.13M sh · $951.79M · Q1 2026
More on CAPITAL WEALTH MANAGEMENT, LLC
FAQ
How long has CAPITAL WEALTH MANAGEMENT, LLC held VRTX?
CAPITAL WEALTH MANAGEMENT, LLC has disclosed VRTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is CAPITAL WEALTH MANAGEMENT, LLC's current position in VRTX?
As of Q3 2026, CAPITAL WEALTH MANAGEMENT, LLC holds 400 shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $209.12K, representing 0.05% of its reported portfolio and ranking #39.
Has CAPITAL WEALTH MANAGEMENT, LLC been buying or selling VRTX?
In the latest 13F filing (Q3 2026), CAPITAL WEALTH MANAGEMENT, LLC newly opened its position in VRTX.
Which other funds hold VRTX?
Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.